Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal bupivacaine versus bupivacaine + fentanyl + dextrose for lower limb orthopedic surgery analgesia
IRCT20190618043934N2Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Feb 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in pain comparing Bupivacaine alone with Bupivacaine + fentanyl + dextrose (2 arms). Primary endpoints: Pain intensity, Duration of analgesia and 3 more. Started Feb 2020; status: completed.
02
Drugs
bupivacainefentanyldextrose
03
Conditions
pain
Beyond the preview
Go deeper on IRCT20190618043934N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190618043934N2.